Amanda Briscoe Presents Veranex an LSI USA ‘23

Transcription

It's very nice to be here. I want to thank the LSI community for having us here today. My name is Amanda and I work for a company called Veranex. Many of you are probably wondering Veranex, haven't heard of that name before. But we are a conglomerate of almost 10 companies that have come together under one umbrella to advise the community not only from an innovation standpoint, but from a commercial commercialization standpoint. You can see here that we have focused our efforts on supporting over 700 plus clients. We have over 1000 programs that range the gamut of services, which I'll talk about in a minute. We are about 1300 and growing employees, focusing on 12 different countries. It's not working, okay. So, as you can imagine, we are a cross functional group we are focusing in on early startup companies as well as mid stage and the large med tech community, we do partner significantly with the large strategics as well. Many of us that work under the very next umbrella have significant relationships as it relates to the investor community as well. Our services range from product design and engineering, preclinical services, we do support clinical evidence generation. So we have clinical development, evidence generation services, as well as the data management and analytics development. We have a strong program and Regulatory Affairs both in the US and outside the US as well as quality assurance, management as well. And then last, but not least, certainly we try to interweave our commercial market access and strategy reimbursement support services inside of what we're offering for companies.

The expertise ranges so we do work across various healthcare sectors, you can see hear that we work within the medical device community, everything from cardiology to neurology, we do work within drug delivery systems as well as diagnostic systems, it and digital extensive experience from the consultants as well as the expertise and in house working within many medical solution areas, everything from minimal, minimal, minimally invasive surgery, all the way through to orthopedics, drug delivery, digital solutions. And as I mentioned earlier, we work with companies from startups, mid size, all the way through to the large strategics. This is just an example of some of the large strategic companies that we have partnered with and continue to partner with to support and unlock innovation. We're really proud to put the slide up on the board. We are the only advisory firm today that's out there that is partnering with Stanford Biodesign. It's an exciting partnership. And we look forward to exploring this with them and you all in the days to come. So there are quite a few of us here at the meeting. Please seek us out. We are looking forward to hearing about all of your innovative, creative medical device technologies and helping you get clearance and helping you with your commercial strategy. And most importantly, helping you to mitigate risk, increasing your time to market and tapping into the industry support that we have underneath the very next umbrella. So with that said, I'm going to go ahead and introduce our first presenter.